Yohimbine has been the subject of the only double-blind, placebo-controlled study to evaluate treatment of sexual dysfunction occurring as a drug side effect. [27] Unfortunately, the placebo ...

Futura Medical’s fast-acting topical erectile dysfunction drug MED2005 shows potential as a first-line treatment, following publication of Phase II trial data in the Journal of Sexual Medicine.

Results from a Phase III study in pediatric patients demonstrated that Odactra reduced the total combined rhinitis score by 22% compared to placebo.

Discover how to deal with these emotions, manage relationship problems, and have a fulfilling sex life despite erectile dysfunction.

(And unlike a pimple, there’s no equivalent of, say, an acne spot treatment.) Rather ... could potentially transfer bacteria between the tube and your eye. (Consider this a cue to organize ...

Understanding the wide clinical spectrum of AOM is needed to help with future clinical trial design and development of a scoring system to establish treatment criteria that will minimize ...

The increased levels of calcium (Ca 2+) in both WB-affected tissues and hypoxic myoblasts suggested that mitochondrial Ca 2+ overload is likely a leading cause for mitochondrial dysfunction that ...

No other corporate actions details are available.